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Abstract
Cell signaling for T-cell growth, differentiation, and apoptosis is initiated in the cholesterol-rich microdomains of the plasma
membrane known as lipid rafts. Herein, we investigated whether enrichment of membrane cholesterol in lipid rafts affects
antigen-specific CD4 T-helper cell functions. Enrichment of membrane cholesterol by 40–50% following squalene
administration in mice was paralleled by an increased number of resting CD4 T helper cells in periphery. We also observed
sensitization of the Th1 differentiation machinery through co-localization of IL-2Ra, IL-4Ra, and IL-12Rb2 subunits with GM1
positive lipid rafts, and increased STAT-4 and STAT-5 phosphorylation following membrane cholesterol enrichment. Antigen
stimulation or CD3/CD28 polyclonal stimulation of membrane cholesterol-enriched, resting CD4 T-cells followed a path of
Th1 differentiation, which was more vigorous in the presence of increased IL-12 secretion by APCs enriched in membrane
cholesterol. Enrichment of membrane cholesterol in antigen-specific, autoimmune Th1 cells fostered their organ-specific
reactivity, as confirmed in an autoimmune mouse model for diabetes. However, membrane cholesterol enrichment in CD4
+
Foxp3
+ T-reg cells did not alter their suppressogenic function. These findings revealed a differential regulatory effect of
membrane cholesterol on the function of CD4 T-cell subsets. This first suggests that membrane cholesterol could be a new
therapeutic target to modulate the immune functions, and second that increased membrane cholesterol in various
physiopathological conditions may bias the immune system toward an inflammatory Th1 type response.
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Introduction
Plasma membrane cholesterol plays a critical role in cell
signaling by stabilizing protein receptors within close proximity to
liquid-ordered phase microdomains called lipid rafts [1]. With few
exceptions, most functional receptors are sequestrated within lipid
rafts prior to ligand ligation and downstream signaling [2]. Lipid
rafts constitute about 30–40% of mammalian cell membranes [3–
6]. Ligand-mediated clustering of neighboring receptor subunits
into rafts leads to the assembly of fully functional receptors able to
signal for T cell development, maturation, activation, and
differentiation [7–10]. These processes occur upon formation of
T cell-APC immunological synapse and TCR- peptide-MHC
complex interactions [11,12]. Clustering of rafts leading to T cell-
APC immunological synapse formation may also occur in a non
antigen-specific manner upon cross-linking of GM1 gangliosides
by bacterial proteins such as cholera toxin B-subunit [13–15] or
cross-linking of carbohydrate moieties of various protein receptors
by galectins [16,17].
Un-esterified cholesterol is the major component of lipid rafts,
and its content is homeostatically regulated by extracellular uptake
from blood circulating LDL [18,19] and de novo intracellular
synthesis [20]. Fine alterations in the amount of membrane
cholesterol lead to re-organization of the lipid raft architecture,
which in turn affects many T-cell functions such as proliferation
[21,22], blunting IL-2 production, or TCR signaling [23,24] by
incomplete or defective coupling of CD3/TCR receptor with its
signaling modules [25–27]. Alterations in the cholesterol-rich lipid
rafts of T-cell membranes can be induced in vitro either by
depletion of cholesterol using cyclodextrins [28], or by cholesterol
addition using hydroxypropyl-b-cyclodextrin [29]. Current ther-
apeutic strategies aimed at immune regulation may also alter
membrane cholesterol content, and thus inadvertently modify the
architecture of protein receptors. Thus, glucocorticoids suppress
the immune system and reduce inflammation in several disease
settings, in part, by preventing compartmentalization of raft-
associated proteins like LAT, LCK, FYN [30]. We and others
show that certain therapeutic HMG-CoA reductase inhibitors like
Lovastatin, a cholesterol lowering drug, can also lower the amount
of T-cell membrane cholesterol and result in altered TCR
signaling [31,32]. Though some pharmaceutical immune regula-
tory agents lower membrane cholesterol while aiming to down-
regulate of T-cell function, little is known about the effect of
membrane cholesterol enrichment on T-cell function.
Early studies using in vivo administration of radio-labeled
squalene demonstrated its ability to integrate into the cholesterol
biosynthetic pathway and generate cholesterol [33]. Squalene is a
late precursor of intracellular cholesterol synthesis that is being
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upon vaccination [34], but its immunomodulatory mechanism(s)
remain largely unknown. Reports indicate that squalene treat-
ment, or as little as 1% of dietary squalene, can limit the
development of preneoplastic lesions involved in colon carcino-
genesis [35237]. In humans, squalene is ubiquitously found in the
blood at very low concentrations due to its rapid turnover [38],
while in the skin and adipose tissue at higher concentrations [39].
Herein, we questioned whether enrichment of membrane
cholesterol in rafts by squalene administration affects cell
differentiation of antigen-specific CD4 T-helper cells and
suppressogenicity of CD4 Foxp3 T-regulatory (T-reg) cells in mice
expressing antigen-specific CD4 T-cells and CD4 Foxp3 T-reg
cells. A single dose of squalene, well below the liver toxicity level,
was followed by a significant increase in membrane cholesterol by
most lymphocyte subsets, particularly by the CD4 T helper and
CD4 Foxp3 T-regulatory (T-reg) cells. This increase in membrane
cholesterol was paralleled by an increase in the number of resting
CD4 T-cells in the spleen, and it favored Th1 differentiation of
CD4 T-cells while having no effect on the suppressogenic function
of CD4 Foxp3 T-regulatory cells.
Material and Methods
Mice
To generate mice bearing antigen-specific CD4 T-cells and
(GFP)-labeled CD4
+Foxp3
+ T-regulatory cells, the HA-specific
TCR transgenic (TCR-HA Tg) mice expressing the 14.3d T-cell
receptor that recognizes the HA110–120-CD4 T-cell immunodo-
minant epitope of the hemagglutinin protein (HA) from the PR8/
A/34 influenza virus [40] were crossed with BALB/c mice
expressing GFP under the Foxp3 promoter (Bar Harbor, Maine,
USA). The F1 hybrids (Foxp3-GFP
+/2, TCR-HA
+/2) were used as
the source of antigen-(HA) specific CD4 T helper and Foxp3
+CD4
T-reg cells. Since the Foxp3 gene is expressed on X chromosome,
Foxp3-GFP
+/+ homozygous females were crossed with TCR-HA
+/+
homozygous Tg males to obtain 100% heterozygous F1
offspring for both the TCR-HA and Foxp3-GFP transgenes.
The F1 hybrids were genotyped by PCR and analyzed by
FACS for Foxp3, GFP, and TCR-HA expression in CD4 T-
cells. Some 30–35% of CD4
+ T-cells and CD4
+Foxp3-GFP
+ T-
cells expressed TCR-HA in the spleen of F1 hybrids as
measured by FACS using a TCR-HA110–120 clonotypic mAb
(#6.5 mAb). The RAG2 KO, RIP-HA Tg mice expressing the
PR8 influenza HA viral protein in the pancreatic b-cell islets
under the rat insulin promoter [40] were used in adoptive cell
transfer experiments as a read-out system for the HA-specific
(diabetogenic) function of TCR-HA CD4 T-cells and for the
regulatory function of CD4 Foxp3 T-reg cells. Adoptively
transferred TCR-HA Tg T-cells in RAG2 KO, RIP-HA Tg
mice induces fulminate diabetes within two weeks post transfer
[41], while the HA-specific CD4 Foxp3 T-reg cells have a down-
regulatory effect on diabetes onset [42,43]. All mice were
housed in pathogen-free conditions at Uniformed Services
University of Health Sciences/Laboratory Animal Medicine
facility. Experiments and care/welfare were in agreement with
the Federal and Local regulations under an approved Institu-
tional Animal Care and Use Committee protocol at Uniformed
Services University of Health Sciences.
Cell Isolation
Single-cell suspensions of CD4
+ or CD25
+ Treg-depleted cells
were prepared by negative sorting from the spleen of untreated or
squalene treated mice. The CD25
hi expression was found on more
than 90% of TCR-HA
+/2, Foxp3-GFP
+/2 T-reg cells by FACS
using triple staining with CD4, Foxp3, and CD25-dye conjugates
(BD Biosciences, San Jose, CA, USA). Negative sorting of cells was
preferred for lipid rafts studies, since positive sorting using specific
antibodies cross-link plasma membrane receptors leads to cluster-
ing and re-organization of rafts, thereby introducing errors in data
interpretation. The CD4
+ splenocytes were negatively-sorted on
mouse CD4 columns (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s instructions. To obtain CD4 T-
cells devoid of CD4
+ CD25
+ (TCR-HA
+/2, Foxp3-GFP
+/2 T-reg)
cells, negatively-sorted CD4 splenocytes were incubated at room
temperature for 30 min. with CD25 Ab (5 mg/10
6 cells, mAb
clone# 7D4, ATTC) followed by incubation with a PE-labeled
anti-CD25 Ab and enrichment on anti-PE antibody-magnetic
beads according to the manufacturer’s instructions (Miltenyi
Biotech, Auburn, CA, USA). The effluent (untouched) cell fraction
was collected as the CD4
+T-reg-depleted cell population. The
Foxp3-GFP T-reg cells from the spleen of Foxp3-GFP
+/2 TCR-
HA
+/2 (F1) hybrids were also negatively-sorted by FACS based on
GFP fluorescence. In some experiments, the HA-specific T-cells
[TIGHER]from both the TCR-HA Tg mice and Foxp3-GFP
+/2
TCR-HA
+/2 (F1) mice were FACS-sorted in cell preparations
stained with the 6.5 mAb clonotypic mAb conjugated to an
APC fluorochrome. The clonotypic 6.5 mAb is a rat IgG1 that
recognizes the TCR-HA110–120 on T-cells. It does not cross-link
the TCR-HA or the rafts, nor trigger TCR signaling [44]. To
isolate splenic APCs, single-cell suspensions of splenocytes were
incubated on a plastic surface in RPMI for 2 h at 37uC, 5%
CO2. The adherent cells were detached by trypsinization,
washed in PBS, and then rested in RPMI for 2 h before
assayed.
In Vivo Protocols
Squalene treatment. Foxp3-GFP
+/2, TCR-HA
+/2 double
transgenic (dTg) mice (F1 hybrids) were injected intraperitoneally
(i.p.) with one or four doses of 180 mg squalene (Sigma, Atlanta,
GA, USA) emulsified 3:1 in saline. At various time-points after the
last injection, the blood, liver and spleen were collected for
histology, in vitro bioassays, serum lipid electrophoresis, FACS
analysis, and adoptive cell transfer experiments. Several splenic
lymphocyte subsets were analyzed for the amount of membrane
cholesterol by FACS at various time-points after the last injection.
Adoptive cell transfer. 2610
5 or 10
4 negatively-sorted
CD25-depleted CD4
+ splenic cells (diabetogenic T-cells), or
representing or CD4 Foxp3-GFP
+/2 T-cells (T-reg cells) from
Foxp3-GFP
+/2 TCR-HA
+/2 (F1) mice were transferred or co-
transferred i.p. into RAG2 KO RIP-HA Tg mice. The onset of
autoimmune diabetes in RAG2 KO RIP-HA Tg recipients was
monitored based on blood glucose values using Accu-Check
glucose meter and glucose test strips (Roche, Indianapolis, IN,
USA). Mice were considered diabetic after two consecutive
readings of glycemia above 200 mg/dL.
Western Blot Analyses
Single-cell suspension of splenocytes or negatively-sorted CD4
+
splenocytes (8.5610
7) from untreated or squalene treated
(180 mg/mouse) F1 mice were prepared 3 days post-squalene
injection. Cells were washed with PBS and lysed for 30 min on
ice in a buffer containing 0.1% SDS, 0.5% NP-40, 10 mM Tris,
150 mM NaCl, 1 mM Na3VO4, 16 mM EDTA, and a cocktail
of protease inhibitors (pH 7, Roche, Indianapolis, IN, USA).
Protein cell extracts were analyzed by SDS-PAGE and Western
blot under denaturing/reducing conditions (1% SDS/0.5% 2-
ME) using 8–25 gradient Phastgels (GE Life Sciences, Piscat-
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Hercules, CA, USA). Gels were either silver-stained or electro-
transferred onto PVDF membranes (Millipore, Billerica, MA,
USA). Transferred membranes were blocked with 5% BSA in
PBS and probed with anti-mouse phosphotyrosine-HRP conju-
gate (R&D). Aliquots of protein cell extracts were precipitated
either with anti-mouse CD3, CD28, IL-4Ra, IL-2Ra, or IL-
12Rb2 Abs for 2 h at room temperature, the immunoprecipitates
were isolated by incubation with agarose-protein A/G beads
(Pierce, Rockford, IL, USA) for 2 h at room temperature, and
the beads were washed twice in PBS, and then boiled for 5 min
in SDS-2ME sample buffer followed by a 5 min centrifugation at
5,000 rpm to remove the agarose beads. Supernatants were then
electrophoresed, and electrotransferred onto PVDF membranes
(Millipore, Auburn, CA, USA) blocked with 5% BSA in PBS and
probed with pan-specific Tyr-phosphorylated HRP-labeled
mouse IgG1 Ab (clone #179003, R&D), or with Abs specific
for phosphorylated ZAP-70, PI3K, STAT-6, STAT-4, or STAT-
5 (Abcam, Cambridge, MA, USA). PVDF membranes were
washed, and bound anti-phospho Abs were detected by isotype
specific secondary anti-IgG-HRP Ab-conjugates (Cell Signaling).
The HRP signal was visualized in a Kodak Imaging Analyzer by
chemiluminescence using a Pierce ECL western blotting substrate
(Pierce, Rockford, IL, USA) according to the manufacturer’s
instructions.
T Cell Bioassays
Single-cell suspensions of splenocytes (10
6 cells) from individual
mice were incubated in round bottom 96-well plates with RPMI
complete media containing HA110–120 synthetic peptide (40 mg/
mL) at 5% CO2 and 37uC. Cytokine secretion in the cell culture
supernatants was measured by Luminex, i.e., 24 h of stimulation
for IL-2 secretion and 36 h of stimulation to measure IL-4 and
IFN-c secretion. For the APC-CD4 T-cell co-culturing experi-
ments, the CD4 T cells (10
6) and APCs (5610
5) from untreated or
squalene treated mice were pulsed or not with HA110–120 synthetic
peptide (40 mg/mL). For the T-cell suppression experiments, T-
regs were co-cultured in 96-well plates with HA-specific CD4 T-
cells at 1:1 ratio (2610
6 total cell number/well) in the presence of
HA110–120 peptide (40 mg/mL) for 48 h at 5% CO2 and 37uC, and
the IL-4 and IFN-c secretion in cell culture supernatants was
measured by Luminex. Cytokines concentration was measured in
Multiplex mouse cytokines kits using a Luminex instrument
(Luminex Corporation, Austin, TX, USA) and a 5 parameter
logistics model equation (MasterplexQT software, Miraibio, San
Francisco, CA, USA) according to the manufacturer’s instructions.
Histology
The liver or spleen from untreated or squalene treated mice was
frozen in Tissue-Tek O.C.T. compound (VWR, Batavia, IL,
USA). Frozen liver sections were mounted on glass slides,
permeabilized with digitonin, and stained for cholesterol with
hematoxylin-eosin and Sudan IV (Histoserv, Germantown, MD,
USA). Images were captured using the Eclipse Nikon microscope
and NIS-Elements AR Nikon software (Nikon, Melville, NY). To
identify cytosolic cholesterol accumulation and lipoidic micro-
droplets, frozen spleen sections were mounted on glass slides and
stained with Oil-red O staining (ORO) and hematoxylin-eosin.
Briefly, mounted spleen sections were stained in 36% Oil red O/
Triethyl phosphate working solution for 10 min (Sigma-Aldrich,
Atlanta, GA, USA), washed in tap water, and then counterstained
with Harris’ hematoxylin (Sigma-Aldrich, Atlanta, GA, USA).
Slides were mounted with VectaShield Hard Set Mounting
medium containing DAPI (Vector Laboratories, Burlingame,
CA, USA) and analyzed by phase contrast microscopy using a
Zeiss instrument (Thornwood, NY, USA).
Phase Contrast and Confocal Laser Scanning Microscopy
(CLSM)
Negatively-sorted CD4 T-cells (10
6 cells) from the spleen of
individual mice previously treated or not with squalene were co-
stained with 1.5 ml CTB-FITC conjugate (Sigma) and anti-CD4
Ab-PE conjugate (BD Biosciences) for 30 min at 4uC, on ice. CTB
is a specific ligand for the GM1 glycosphingolipid resident moieties
of the lipid rafts [45]. To visualize the IL-2Ra, IL-4Ra, or IL-
12Ra subunits that co-localize with the lipid rafts of negatively-
sorted CD4 T-cells (10
6 cells), single cell suspensions (10
6 cells)
were co-stained with specific anti-receptor Ab-PE conjugates (BD
Biosciences) and CTB-FITC conjugate. Stained cells were washed
twice in PBS/BSA 1% and mounted onto glass slides using
Vectashield containing DAPI stain (Vector Laboratories Inc.,
Birmingham, CA) to identify cell nuclei. Distribution of GM1
resident moiety in the cholesterol-rich rafts of plasma membrane
was captured as 2D images, and the GM1 content was measured
based on CTB-FITC cell intensity using a ZEISS 710 Confocal
Laser Scanning Microscope equipped with ZEISS ZEN 2009
analysis software (Thornwood, NY, USA). To analyze receptor co-
localization with the lipid rafts, resting CD4 T-cells from the
squalene treated or untreated mice were triple stained with DAPI,
GM1-CTB, and either anti IL-2Ra-APC, anti-IL-4Ra-PE, or
anti-IL-12Rb2-PE conjugates (BD Biosciences).
Flow Cytometry
Single-cell suspension of splenocytes (10
6 cells) from untreated
or squalene treated mice were stained for 30 min at 4uC for
surface markers or intracellular cytokine synthesis using specific
antibody-dye conjugates (BD Biosciences) or their isotype controls.
In some experiments, cells were co-stained with Filipin III (Sigma)
to measure the amount of cholesterol in the plasma membrane.
Mean fluorescence intensity (MFI) of Filipin III or Ab-dye
conjugates was measured by FACS at the single-cell level in
10
4–10
5 cell events acquired with a LSR II Becton-Dickinson
instrument equipped with the WINLIST analysis software (Verity,
Topsham, ME, USA). FACS measurements of membrane
cholesterol was estimated by the MFI values of Filipin III as
described [46]. Filipin III binds specifically to un-esterified
cholesterol present in the plasma membrane of lipid rafts [47].
Spectrophotometric measurements between lexcitation=340 and
380 nm and lemission=385–470 nm ruled out the possibility that
Filipin may stain squalene possibly attached or incorporated into
the plasma membrane.
Real-time RT-PCR
Total RNA and cDNA from splenocytes was extracted using
Pure-Link Micro and Midi RNA Purification Systems (Invitrogen,
Carlsbad, CA, USA) and High Capacity cDNA Archive kit
(Applied Biosystems, Foster City, CA, USA), respectively. The
primers for murine HMG-CoA reductase were forward-
59GAATGCCTTGTGATTGGAGTTG39, and reverse-
59GCCGAA GCAGCACATGATCT39; specific primers for
Squalene epoxidase, T-bet, GATA-3, IL-2Ra, IL-12Rb2, and
IL-4Ra were purchased from Applied Biosystems. Measurement
of gene products expression was carried in an ABI Prism 7700
equipped with SDS 1.9.1 analysis software (Applied Biosystems), as
previously described [48]. The relative mRNA levels were
estimated in reference to the 18S rRNA (Applied Biosystems).
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Fresh mouse serum from untreated or squalene treated mice
was assessed for the fractions of high density lipoproteins (HDL),
low density lipoproteins (LDL), and very low density lipopro-
teins (VLDL) using the QuickGel Cholesterol kit and an
electrophoretic system from Helena Laboratories (Beaumont,
TX, USA) according to the manufacturer’s protocol. The
lipoprotein fractions were quantified based on the number and
intensity of pixels per each electrophoretic band using the
SCION Image analysis software (Scion Corp. Frederick, MD,
USA).
Statistics
Significance of results between untreated and squalene treated
groups for the MFI values measured by FACS, cytokines
concentration in Luminex, RNA expression level in RT-PCR,
and blood glucose values, was determined by the unpaired
Student’s t-test for which *p values less than 0.05 were considered
significant. For each cytokine, means were also compared across
groups using one-way analysis of variance (ANOVA) followed by
Tukey’s post-hoc pairwise comparisons. *p values,0.05 were
considered statistically significant.
Results
Squalene Treatment Up-regulates Membrane Cholesterol
in Various Lymphocyte Subsets
Squalene is a late cholesterol precursor that can be efficiently
taken up by hepatocytes and converted into cholesterol when
administered intravenously [33]. Herein, we measured the content
and distribution of membrane cholesterol in various splenic
lymphocyte subsets following i.p. injection of squalene (emulsified
3:1 in saline) in F1 hybrid mice (TCR-HA
+/2, Foxp3-GFP
+/2
mice).
F1 mice were treated i.p. with 0, 1, or 4 doses of squalene
(180 mg/dose). Seven days after the last injection, negatively-
sorted, resting CD4 splenic T-cells from each group were stained
with filipin and analyzed for the amount of membrane cholesterol
by FACS. The kinetics of membrane cholesterol accumulation in
resting CD4 T-cells from F1 mice given a single dose of squalene
(180 mg/mouse) indicated that the peak cholesterol load occurs
after 7 days, with a gradual decrease within the following two
weeks till reaching physiological levels (data not shown). Four
injections of squalene (180 mg/dose/mouse) administered within a
week interval significantly increased the amount of membrane
cholesterol in CD4 T-cells (45% MFI increase) as compared with
those from untreated (control) mice. However, no significant
difference was observed between mice given one or four doses of
squalene (40% vs. 45% MFI increase) (Figure 1A). This may be
explained by the saturation limit of either the cellular uptake of
squalene or the intracellular trafficking of cholesterol from the
cytosol to the plasma membrane in CD4 T-cells. A slight
homogenous accumulation of cholesterol in the spleen was
visualized by phase contrast microscopy in oil-red-o stained
cross-sections from F1 mice treated with 4 doses but not a single
dose of squalene (Figure 1B). Membrane cholesterol accumula-
tion in resting CD4 T-cells upon squalene administration
appeared to be an active process regulated by genes involved in
cholesterol synthesis, since an increase in the mRNA expression
levels of HMG-CoA reductase and Squalene epoxidase by 30%
and 15% respectively, was detected 3 days after a single dose of
squalene (Figure 1C).
We have previously shown that accumulation of membrane
cholesterol in resting CD4 T-cells is a developmental feature and
that the content of membrane cholesterol is stable between 2 and 4
months of age in mice [49]. To avoid physiological alterations in
T-cell membrane cholesterol content, all experiments were carried
out in 3 month-old F1 mice when the amount of membrane
cholesterol is most stable.
Seven days after a single dose of squalene (180 mg/mouse),
single-cell level flow cytometry analysis revealed that the amount
of membrane cholesterol in CD4 Foxp3 splenic T regulatory cells
was also increased by 40 to 50% (Figure 1D). Resting B-cells, and
dendritic cells from the spleen of F1 mice given a single dose of
squalene (180 mg/mouse) also showed an increase (5–10%) in
membrane cholesterol, albeit less dramatic when compared to
CD4 and CD8 T-cells (Figure S1).
A single-dose of squalene administration (180 mg/mouse) was
consistently associated with altered CD4 T-cell frequencies
within the pool of resting splenocytes, as analyzed by flow
cytometry 7 days post-injection. Thus, the number of resting
CD4 T-cells was increased by 20–22%, whereas the number of
CD4 Foxp3 T-cells, CD8 T-cells, CD19
+ B-cells, and CD11c
+
dendritic cells remained relatively unchanged (Figures 1A
(right panel), 1D and S1). Furthermore, CLSM analysis of the
resident lipid raft marker GM1 in negatively-sorted, resting
CD4 splenic cells from F1 mice injected with a single dose of
squalene (180 mg/mouse) showed that membrane cholesterol
enrichment was associated not only with a higher GM1
expression, but also with a more homogeneous distribution as
compared with lower GM1 expression and more heterogeneous
distribution in resting CD4 splenic cells from untreated mice
(Figure 2). A narrow fluorescence intensity peak observed by
CLSM analysis (Figure 2, bottom right panel) indicates a
narrow range of GM1 homogeneity within a given cell
population, such that the majority of cells express the same
amount of GM1. In contrast, a broad fluorescence intensity
peak refers to a wide range of GM1 heterogeneity within a
given cell population. Thus, the cell population is comprised of
a mixture of cells expressing high, intermediate, low, and very
low amount of GM1. (Figure 2, bottom left panel).
To determine the extent to which in vivo squalene administration
may affect cholesterol metabolism in the liver, the electrophoretic
profile of serum cholesterol fractions and rate of cholesterol
accumulation in liver were analyzed. F1 mice given a single dose of
squalene (180 mg/mouse) showed no significant alterations in the
ratio of serum cholesterol fractions or cholesterol accumulation in
the liver 7 days post-injection (data not shown). However, four
doses of squalene (180 mg/dose/mouse) administered once a week
led to an increase in the high density lipid fraction (HDL) in serum
7 days after the last injection (Figure S2-A), and a modest
accumulation of cholesterol in liver tissue (Figure S2-B). Of note,
all biofunctional assays in this study were carried out in 3 month-
old F1 mice injected with a single i.p. dose of squalene (180 mg/
mouse), for which no alterations in serum cholesterol fractions or
liver cholesterol accumulation were detected. Early studies showed
that LDL serum cholesterol increases upon inhibition of hepatic
squalene synthesis by zaragozic acid [50]. In contrast, we found
that squalene administration was paralleled by an increase in HDL
serum cholesterol.
In summary, these results indicate that exogenous squalene
can be efficiently taken up by various subsets of resting
peripheral lymphocytes and is constantly associated with an
increase in membrane cholesterol, particularly in resting CD4
T-cells. Squalene administration was also followed by an
increased frequency of resting CD4 T-cells (,20% increase),
but had no significant effect on the frequency of CD4 Foxp3 T-
reg cells, CD8 T-cells, B-cells, and dendritic cells in the spleen.
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Sensitizes the Th1 Signaling Modules in the Absence of
T-cell Stimulation
Cholesterol-rich plasma membrane microdomains (lipid rafts)
play a critical role in early intracellular signaling towards many cell
functions.Thesesignalingeventscanbedetectedbyphosphorylation
ofvariousproteinreceptorsandtheiradaptormolecules,aswellasby
the recruitment of various kinases to their intracellular domains.
Herein,wequestionedwhetherenrichmentofmembranecholesterol
in resting CD4 splenic T-cells may alter the baseline of tyrosine
phosphorylation in several signal transduction molecules critical for
cell differentiation. First, the protein patterns from total lysates of
negatively-sorted, resting CD4 splenic T-cells from untreated or
squalene treated (180 mg/mouse) F1 mice showed no detectable
quantitative alterations 3 days post-injection, as the number and
intensityofSDS-PAGEproteinbandsweresimilarinbothgroupsof
mice(Figure3A).However,amodestincreaseinthe55to100 kDa
tyrosine phosphorylated proteins was detected in the T-cell lysates
from squalene treated mice (Figure 3B).
Analysis of several protein kinases and transducer molecules
required for downstream signaling of T-cell differentiation, i.e., IL-
12R, IL-4R and their signaling molecules, revealed a differential
modulatoryeffectofmembranecholesterolinrestingCD4T-cellsin
the absence of antigen stimulation (Figure 3C). During T-cell
differentiation, binding of IL-12 to IL-12Rb2 leads to STAT-4
phosphorylationinTh1cells[51],whereasbindingofIL-4toIL-4R
leadstoSTAT-6phosphorylationinTh2cells[52].Datadepictedin
Figures 3C and 3D showed that resting CD4 splenic T-cells
enriched in membrane cholesterol had an increased baseline of
STAT-4 phosphorylation and a decreased baseline of STAT-6
phosphorylation.Anumberofadditionalsignalingeventssupporting
the T-cell growth and survival also occur during Th1 cell
differentiation.Thus,bindingofIL-2toIL-2Rpromotesrecruitment
and phosphorylation of JAK kinases on the IL-2Rb chain, which in
turnmediatestheassemblyofafullyfunctionalIL-2Rabcfollowedby
STAT-5 phosphorylation, heterodimerization, and translocation to
thenucleuswhereitbindstorestrictionelementsinthegenepromoter
ofseveralgenes.[53,54].ThebasallevelofphosphorylatedSTAT-5
wasincreasedinrestingCD4T-cellsuponenrichmentofmembrane
cholesterol (Figure 3C). Furthermore, during Th1 differentiation
theCD3chainsareassembledtogetherwiththeTcellreceptor(TCR)
aandbchainsinthecellmembranetoformafullyfunctionalCD3/
TCR complex. The f-chain of CD3/TCR complex possesses
Figure 1. Squalene administration leads to accumulation of membrane cholesterol in resting CD4 T-cells. (A) F1 hybrid mice (n=5/
group) were injected i.p. or not (purple line) with a single dose (black line) or 4 doses of squalene (red line) within a week interval (180 mg/dose/
mouse). Seven days after the last injection, negatively-sorted splenic CD4 cells from individual mice were co-stained with CD3-PE, CD4-FITC and
Filipin III. Shown is the amount of cholesterol in plasma cell membrane of gated CD3
+CD4
+ splenic cells as measured by MFI of Filipin III in FACS at
single-cell level in one representative mouse from each group (left panel). Right panel, F1 hybrid mice (n=7/group) were injected i.p. (black line) or
not (red line) with a single dose of squalene (180 mg/mouse) and 7 days later negatively-sorted splenic CD4 cells from individual mice were co-stained
with CD3-PE, CD4-FITC, and Filipin III. Shown is the percentage of gated CD4
+ T-cells 6 standard deviation (SD) and MFI values of Filipin III 6 SD
before and after squalene injection as collected among 700 cell events in gated population of CD3
+4
+ T-cells for one of three representative
experiments. (B) Cholesterol accumulation in the spleen was identified by Oil Red O (ORO) staining of frozen spleen sections, counter-stained with
hematoxylin from untreated or squalene treated mice (180 mg/mouse) given one or four doses, and analyzed 7 days post-injection (n=3/group). Left
panel, spleen section from untreated mouse. Middle panels, spleen section from squalene treated mice. Right panel, positive control for ORO lipid
droplet staining in adipocytes. Shown is one representative ORO stained section in each group. Dark arrows indicate ORO stain. (C) Quantitative real-
time RT-PCR of HMG-CoA reductase mRNA and Squalene epoxidase mRNA extracted from negatively-sorted CD4 splenocytes isolated from individual
F1 hybrid mice (n=5/group) that were treated (light bars) or not treated (dark bars) with a single dose of squalene (180 mg/mouse) and analyzed 7
days post-injection. Y axis indicates the mean fold increase in mRNA expression level relative to the endogenous 18S rRNA expression level (control 6
standard deviation (SD). Shown are two combined separate experiments (*p value,0.05). (D) FACS measurements of CD3
+4
+Foxp3
+ T-reg cells from
negatively-sorted CD4
+ splenic cells of the same F1 mouse groups analyzed in panel A that were co-stained with CD3-PE and Filipin III. Shown is the
percentage of gated CD4
+Foxp3
+ T-reg cells 6 SD and MFI values of Filipin III 6 SD collected among 500 cell events in the gated population of GFP
+-
Foxp3/GFP
+ cells from one mouse in each group from two representative experiments.
doi:10.1371/journal.pone.0038733.g001
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docking of phosphorylated ZAP-70 [55]. Membrane cholesterol
enrichment in resting CD4 splenic T-cells led to an increased base
level of phosphorylated ZAP-70 kinase (Figure 3C). In addition to
CD3/TCR and cytokine receptor signaling, CD28 co-stimulation
through ligation by B7 molecules expressed by APCs provides
sustained CD3/TCR signaling and promotes Th1 cell survival
[55,56]. An early event of CD28 ligation is the recruitment and
phosphorylation of PI3K on its intra-cytoplasmic tail. Our data
consistently showed that enrichment of membrane cholesterol in
resting CD4 splenic T-cells had little if any effect on the phosphor-
ylation and recruitment of PI3K to the CD28 intra-cytoplasmic tail
(Figure 3C).
Further analysis of resting CD4 splenic T-cells from F1 mice
treated or not with squalene was carried out by CLSM to visualize
the membrane distribution of IL-12Rb2 and IL-4Ra subunits that
recruit STAT-4 in Th1 differentiating cells and respectively
STAT-6 in Th2 differentiating cells. CLSM analysis of IL-2Ra
revealed a differential co-localization of this receptor subunit with
the lipid rafts, as well as IL-4Ra and IL-12Rb2, 7 days after
squalene treatment. In differentiating CD4 T-cells, the autocrine
IL-2 secretion and IL-2R up-regulation on cell surface play a
critical role for the cell growth and proliferation. The first
observation was that these receptor subunits were easily detected
in the rafts upon squalene treatment (Figure 4). Secondly, the IL-
2Ra and IL-4Ra subunits were observed as capping in rafts
microdomains, whereas the IL-12Rb2 subunit was more dispersed
in the rafts (Figure 4, enlargements). Third, squalene treatment was
paralleled by increased mRNA expression level, particularly for
IL-4Ra and IL-12Rb2 subunits in resting CD4 T-cells
(Figure 5A). Fourth, the level of cell surface expression of either
receptor was not significantly increased by squalene treatment as
determined by the MFI values in single-cell level FACS analysis
(Figure 5B). Conceivably, a differential receptor re-distribution in
the rafts detectable by CLSM implies that the unique structure of
each receptor and the amount of cholesterol in the microdomains
could both play important roles. The mechanism by which
spatiotemporal re-organization of IL-2R, IL-4R, and IL-12R in
the rafts microdomains of resting CD4 T-cells upon membrane
cholesterol enrichment remains to be further investigated.
Together, these data indicate that enrichment of membrane
cholesterol in resting CD4 T-cells by 40 to 50% can sensitize the
Th1 signaling machinery by means of rafts re-distribution of
cytokine receptors and increased phosphorylation of signaling
modules critical for Th1 cell differentiation.
Cholesterol Enrichment in the CD4 T-cell Membrane
Fosters Type 1 Cell Differentiation in the Presence of T-
cell Stimulation
SinceenrichmentofmembranecholesterolinrestingCD4T-cells
increasedthephosphorylationofsignalingmodulesinvolvedinTh1
differentiation in the absence of T-cell stimulation, we next
investigated whether enrichment of membrane cholesterol in CD4
T-cells and/or antigen presenting cells (APCs) under stimulation
may affect the outcome of T-cell differentiation. For this, the
cytokine secretion profiles from various combinations of negatively-
sorted CD4 T-cells and APCs isolated from untreated or squalene
treated(180 mg)F1mice(HA110–120-specificTCR)wereanalyzedin
the presence of antigen-specific (HA110–120) stimulation or non
antigen-specific CD3/CD28 polyclonal stimulation.
Co-cultures of membrane cholesterol-enriched, resting CD4 T-
cells and HA110–120 pulsed APCs enriched in membrane
cholesterol showed the highest secretion of IL-2 and IFN-c and
the lowest IL-4 secretion (Figure 6A). The amount of IL-2 and
IFN-c secreted by resting CD4 T-cells stimulated with HA110–120-
pulsed APCs was 30–35% lower when T-cells were not enriched in
membrane cholesterol, indicating that membrane cholesterol
enrichment in both CD4 T-cells and APCs provides the strongest
Th1 polarization. Thus, while the HA-specific CD4 T-cells
stimulated with HA110–120 peptide usually developed a Th1/Th2
mixed response, those from squalene treated mice developed a
predominant Th1 response. Because membrane cholesterol
enrichment in APCs augmented IFN-c secretion by antigen-
specific CD4 T-cells, and IL-12 secretion by APCs is known to up-
regulate IFN-c secretion by CD4 T-cells, we next compared the
steady-state of IL-12 secretion by unstimulated APCs from
untreated and squalene treated F1 mice. The baseline of IL-12
secretion was near the limit of detection in APCs cultured from
untreated (control) mice, while being significantly higher in APCs
cultured from squalene treated mice (Figure S3). This may well
explain why IFN-c secretion by CD4 T-cells was significantly
augmented in the presence of HA-pulsed APCs enriched in
membrane cholesterol. The base level of IL-6 secretion, but not
Figure 2. Squalene induced accumulation of membrane
cholesterol in resting CD4 T-cells alters the partitioning of
lipid rafts. Negatively-sorted CD4
+ splenocytes were isolated from the
spleen of untreated or squalene treated (single 180 mg dose/mouse) F1
mice 7 days post-injection. Cells were co-stained with CD4-PE, CTB-FITC
and DAPI and analyzed by CLSM. Upper panels, quadrants indicating
single-color stained cells at X40 magnification from untreated (left
column) and squalene treated F1 mouse (right column): upper left
quadrant, CTB-FITC staining (green); upper right quadrant, CD4-PE stain
(red); lower left quadrant, DAPI staining of nuclei (blue), and lower right
quadrant, merged channels for CTB-FITC, CD4-PE and DAPI staining.
Middle panels, merged CTB-FITC, CD4-PE and DAPI staining of clusters of
splenocytes from untreated and squalene treated F1 mouse at X220
magnification. Bottom panels, color intensity quantification for cell
clusters shown in the middle panels using the using the ZEISS ZEN 2009
analysis software. Of note, the amount of GM1 moiety revealed by CTB-
FITC (green) in merged channel 2 is significantly higher for the CD4 T-
cells from squalene treated mouse than that of the untreated mouse.
Shown is one of three mice analyzed in each group.
doi:10.1371/journal.pone.0038733.g002
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membrane cholesterol enrichment (Figure S3), which indicated
a differential effect of membrane cholesterol not only on CD4 T-
cell function, but also on APC function.
Furthermore, total spleen cells harvested 7 days after squalene
injection were stimulated in culture with CD3/CD28 Abs. These
cultures showed a larger number of proliferating CD4 splenic T-
cells positive for intracellular IFN-c than for IL-4 detected by
FACS (Figure 6B). This corresponded with a significant 8 fold-
increase in T-bet mRNA expression and only a 2 fold-increase in
GATA-3 mRNA expression measured by real-time RT-PCR
(Figure S4).
Together, the results demonstrate that stimulation of CD4 T-
cells leads preferentially to a Th1 response when plasma
membrane cholesterol is enriched by 40–50%. The Th1 response
was more vigorous when APCs were also enriched in membrane
cholesterol, as they secreted higher amounts of IL-12, a major
cytokine driving Th1 cell differentiation.
Enrichment of Membrane Cholesterol Fosters the
Reactivity of Autoimmune Th1 Cells
To determine whether membrane cholesterol enrichment by in
vivo squalene administration alters the reactivity of antigen-specific
(HA110–120) Th1 cells in vivo, we took advantage of a RAG2 KO,
RIP-HA Tg mouse model in which autoimmune diabetes (type 1
diabetes, T1D) is induced by i.p. infusion of splenic CD4 T-cells
(2.5610
5 cells) from TCR-HA Tg mice. In this model of inducible
T1D, hyperglycemia is detected within 7 to 10 days after transfer
of diabetogenic, HA110–120-specific Th1 cells [57].
Using this T1D mouse model, we first tested our F1 hybrid
mouse for the expression level and diabetogenicity of TCR-
HA
+/2 CD4
+ (Foxp3
2/2) T-cells in the spleen. Similar to the
parental TCR-HA
+/+ homozygous Tg mice, the spleen of F1
hybrid mice expressed ,40% of TCR-HA
+/2 CD4
+ (Foxp3
2/2)
T-cells according to FACS measurements using a TCR-HA
clonotypic antibody (# 6.5 mAb). The spleen of F1 hybrid mice
also contained a similar number of CD4
+ Foxp3-GFP
+/2 T-reg
cells as the parental Foxp3-GFP
+/+ homozygous Tg mice (1–
3%). The diabetogenic potential of TCR-HA
+/2 Tg CD4
splenic T-cells from F1 hybrid mice (TCR-HA
+/2, Foxp3-GFP
+/
2 dTg mouse) was tested by transferring i.p. 2.5610
5
negatively-sorted CD4
+ (Foxp3-GFP)
2/2 splenic T-cells into
RAG2 KO, RIP-HA Tg mice. The RAG2 KO, RIP-HA Tg
recipients developed hyperglycemia by 8–10 days after cell
transfer, whereas those receiving either CD4
+ (Foxp3-GFP)
+/2
T-reg cells from the same F1 donors or CD4 splenic T-reg cells
from Foxp3-GFP
+/+ Tg parental mice did not (Figure 7A). This
Figure 3. Tyrosine phosphorylation patterns of major signaling modules of T helper differentiation upon enrichment of membrane
cholesterol. (A) SDS-PAGE silver stain of pooled, negatively-sorted CD4
+ splenic T-cell lysates from F1 mice (n=4/group) untreated (left lane)o r
squalene treated (single dose of 180 mg, right lane) 3 days post-injection shows no detectable quantitative alterations in the protein bands between
the two groups of mice. (B) Tyrosine phosphorylation patterns of the same samples in panel A were blotted with anti-phosphorylated tyrosine Ab-
HRP conjugate. Of note, the amount of 55–100 kDa phosphorylated protein bands is increased in mice treated with squalene. (C)
Immunoprecipitation of pooled splenic CD4
+ T-cell lysates from F1 mice treated or not with squalene (180 mg/mouse, n=4/group) 3 days post-
injection was carried out for IL-12Rb2, IL-2Ra, IL-4Ra, CD28, or CD3 receptors using specific Abs, and probed with specific anti-phospho Abs for
STAT4, STAT5, STAT6, PI3K, and ZAP-70 kinases. Only the phosphorylated STAT-4, STAT-5, and ZAP-70 in squalene treated mice were significantly
enhanced. Shown is one of two representative experiments.
doi:10.1371/journal.pone.0038733.g003
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+TCR-HA
+/2 (Foxp3-
GFP
2/2) splenic T-cells, but not the CD4
+ TCR-HA
+/2 Foxp3-
GFP
+/2 or CD4
+Foxp3-GFP
+/+ splenic T-reg cells have
diabetogenic potential.
To determine whether enrichment of membrane cholesterol in
CD4
+TCR-HA
+/2 (Foxp3-GFP
2/2) may affect their diabetogenic
potential, splenocytes from untreated and squalene treated F1mice
(180 mg squalene/mouse) were isolated 7 days post-injection and
depleted of CD4
+Foxp3-GFP
+/2 T-regs, followed by negative-
sorting of diabetogenic CD4
+TCR-HA
+/2 T-cells. Purified
diabetogenic CD4
+(Foxp3-depleted) TCR-HA
+/2 T-cells (1610
4
cells/mouse) from squalene treated or untreated F1 mice were
then transferred into RAG2 KO, RIP-HA Tg mice, and glycemia
(read out for T1D onset) was monitored bi-weekly. Data depicted
in figure 7B show that the cumulative incidence of hyperglyce-
mia in RAG2 KO, RIP-HA Tg recipients of diabetogenic
CD4
+(Foxp3-depleted), TCR-HA
+/2 T-cells from untreated F1
mice was 50%, whereas in those receiving the same type of cells
from squalene treated F1 mice was increased to almost 80%.
These results indicated that the enrichment of membrane
cholesterol in self-reactive (diabetogenic) Th1 cells fostered their
diabetogenic potential.
Cholesterol Enrichment in CD4 Foxp3 T-reg Cell
Membrane does not Affect their Suppressogenic
Function
Naturally-born CD4 T-cells expressing the master regulatory
gene Foxp3 are the archetype of T-regulatory (T-reg cells). T-reg
cells maintain T-cell and B-cell homeostasis and can also restrict
immune responses to various self and foreign antigens [58]. We
have shown above that a single dose of squalene (180 mg/mouse)
resulted in a 40 to 50% increase of membrane cholesterol in CD4
Foxp3 T-reg cells (Figure 1D). We next investigated whether their
function was altered by membrane cholesterol enrichment. For
this, resting CD4 T-cells expressing the HA110–120-specific TCR
(T effector cells, T-eff) were negatively-sorted from the spleen of
untreated or squalene treated (180 mg/mouse) F1 mice 7 days
post-injection. FACS-sorted GFP
+ T-reg cells were also negatively-
sorted by FACS from the spleen of untreated or squalene treated
(180 mg/mouse) F1 mice 7 days post-injection. The supernatants
from 2-day co-cultures of several combinations of T-reg cells and
CD4 T-eff cells in the presence of HA110–120-pulsed APCs from
untreated or squalene treated F1 mice were further assessed for the
secretion of IL-2 and major Th1 and Th2 cytokines (IFN-c and
IL-4, respectively) in parallel with mRNA expression level of T-
Figure 4. Co-localization of cytokine receptors with lipid rafts of resting CD4 T-cells before and after squalene treatment. Resting
CD4 T-cells from individual F1 mice (n=5/group) before and 7 days after squalene treatment (180 mg/mouse) were analyzed for interleukin receptor
expression and distribution at the single-cell level by CLSM. Cells were stained with IL-4Ra-, IL-12Rb2-, or IL-2Ra-PE conjugates, and co-stained for
GM1 ganglioside by CTB- FITC conjugate and for nuclei with DAPI. First column indicates single-channel color for DAPI staining (blue), second column
indicates GM1 staining (green), third column indicates interleukin receptor (IL-Rs) staining (red), and last column indicates merged channels at X63
magnification. Top-two rows, indicate cells from untreated (upper row) and squalene treated mice (lower row) stained for IL-4Ra. Middle-two rows,
indicate cells from untreated (upper row) and squalene treated mice (lower row) stained for IL-12Rb2. Bottom-two rows, indicate cells from untreated
(upper row) and squalene treated mice (lower row) stained for IL-2Ra. Arrows indicate presence of IL-Receptor co-expression with the GM1 resident of
lipid rafts. Enlargements of the merged channels are depicted to the right along with two different angles of the membrane for each IL-Receptor at
X220 magnification. Shown are representative images in one of three experiments.
doi:10.1371/journal.pone.0038733.g004
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in Th1 cells. We previously reported that the level of T-bet mRNA
expression strongly correlates with the suppressogenic capacity of
CD4 Foxp3 T-regs on the proliferation and cytokine secretion of
conventional CD4
+(Foxp3
-) T-cells (T-eff cells) [48].
Interestingly, if considering the effect of membrane cholesterol
on CD4 Th1 differentiation in the previous experiments, the CD4
Foxp3 T-regs were able to induce similar levels of suppression on
IL-2, IFN-c, and IL-4 secretion by conventional CD4 T-cells (T-
eff cells) regardless of membrane cholesterol enrichment
(Figure 8A). This was consistent with a lack of alteration in the
T-bet mRNA expression in T-effector cells, as determined by real-
time RT-PCR (Figure 8B).
Discussion
Cholesterol-rich microdomains known as lipid rafts are postu-
lated to be a driving force in immunological synapse formation
and critical for T-cell signaling [1,59–61].
Squalene is a late precursor of cholesterol that is readily
incorporated by hepatocytes and proficiently integrated into the
cholesterol biosynthesis pathway after intravenous administration
in humans [33]. Herein, we found that a single intraperitoneal
injection of squalene leads to a significant enrichment of
membrane cholesterol in resting lymphocytes, i.e., CD4 T-cells,
CD8 T-cells, B-cells, and dendritic cells in mice. The plasma
membrane of CD4 T-cells and CD4 Foxp3 T-reg cells showed a
40–50% increase in membrane cholesterol above baseline after
one dose of squalene, most likely due to an initially lower baseline
of membrane cholesterol as compared with other lymphocyte
subsets. Squalene enrichment of membrane cholesterol was
paralleled by an increased number of resting CD4 splenic T-cells
in the absence of T-cell stimulation. This was consistent with early
studies showing that provision of cholesterol through high and low
density lipoproteins sustains a continuous homeostatic prolifera-
tion of T lymphocytes [62–64]. Recently, a cholesterol-rich diet or
hypercholesterolemia in mice was associated with an increased
number of splenic CD4 T-cells [65]. In contrast, atorvastatin-
induced inhibition of HMG CoA reductase, a critical enzyme
required for cholesterol synthesis, led to a reduction in the number
of T-cells in humans [66]. The molecular mechanism(s) by which
membrane cholesterol promotes lymphocyte proliferation remains
largely unknown. We found that squalene enrichment of
membrane cholesterol in resting CD4 T-cells was paralleled by
increased IL-2 secretion, a powerful autocrine growth factor for T-
cells. This may well explain why the rate of homeostatic
proliferation was increased in resting CD4 T-cells enriched in
membrane cholesterol.
Spatiotemporal partitioning of protein receptors in lipid rafts
influences their signaling status in T-cells, not only in a ligand-
specific manner but also by re-partitioning of neighboring
receptors and co-receptors [67]. We questioned whether squalene
enrichment of membrane cholesterol in the absence of TCR
ligation may affect the spatiotemporal partitioning of protein
receptors and consequently the tyrosine phosphorylation events
critical for recruitment of signaling kinases in CD4 T-cells. The
protein synthesis in resting CD4 splenic T-cells was quantitatively
unaltered after enrichment of membrane cholesterol. However,
fine alterations in tyrosine phosphorylation of several signaling
modules associated with receptors involved in Th1/Th2 cell
differentiation were detected. Higher amounts of phospho-STAT-
4 recruited on IL-12Rb2, phospho-STAT-5 on IL-2Ra, and
phospho-ZAP-70 recruited on TCR/CD3 complex were detected
in resting CD4 T-cells enriched in membrane cholesterol, in
contrast to phospho-STAT-6 recruited on IL-4Ra that dropped
below baseline. Increased ability of IL-12Rb2 to recruit phospho-
STAT-4 and of IL-2Ra to recruit phospho-STAT-5 was consistent
with increased IFN-c, and respectively IL-2 secretion upon CD3/
CD28 ligation [68]. These protein receptors have a particular
partitioning in the lipid rafts of resting T-cells. Thus, most of TCR
a and b chains in resting T-cells reside in the non raft domains,
whereas the f-chain resides in the raft microdomains [69,70]. The
IL-12Rb2 is mostly located in the non-raft microdomains, whereas
IL-12Rb1 is located in the raft microdomains, and the ligation
through IL-12 leads to a functional IL-12R [71]. The IL-2Ra-
chain (CD25) is mostly located in the rafts of resting CD4 T-cells
independent of ligation by IL-2 [68,72], whereas the IL-2Rb-chain
is mostly located in the non-raft microdomains [73]. While the IL-
2Ra-chain binds IL-2 with high affinity and lacks signaling ability,
the intracellular tail of IL-2Rb-chain expresses several tyrosine
phosphorylated sites as docking sites for JAK kinases, which in
turn mediates STAT-5 phosphorylation and dimerization. It has
been suggested that a functional IL-2Rabc able to promote
phosphorylation/dimerization of STAT-5 is assembled mostly in
the non-raft microdomains of the plasma membrane [74]. The IL-
Figure 5. Alteration in cytokine receptors mRNA expression
after squalene enrichment of membrane cholesterol in resting
lymphocytes. (A) Quantitative real-time RT-PCR of IL-4Ra, IL-12Rb2,
and IL-2Ra mRNA extracted from peripheral blood lymphocytes of
individual F1 mice (n=5/group) analyzed before squalene treatment
(dark bars) and 7 days after squalene injection (180 mg/mouse) (light
bars). Y axis indicates the mean fold increase in mRNA expression level
relative to the endogenous 18S rRNA expression level (control 6 SD).
Shown are two combined separate experiments (*p values,0.05). (B)
Aliquots samples in panel A were stained with CD4-FITC conjugate, co-
stained either with IL-4Ra-PE or IL-12Rb2-PE or IL-2Ra-PE conjugates,
and analyzed by FACS at the single-cell level for the surface IL-Rs
expression level based on MFI measurements. Shown are the IL-Rs MFI
values 6 SD measured in individual mice before and after squalene
treatment. Of note, no significant changes occurred in the IL-Rs
expression on cell surface after squalene treatment (*p values.0.05).
doi:10.1371/journal.pone.0038733.g005
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common c chain to form a functional receptor [75].
Interestingly, the ability of the CD28 receptor to recruit PI3K
was not affected by membrane cholesterol enrichment in resting
CD4 T-cells. The CD28 receptor resides mostly in the raft
microdomains during T-cell signaling [76]. These opposing
signaling events that occurred solely by cholesterol enrichment
in the plasma membrane, strongly suggest that not only receptor
ligation but also an increase in rafts cholesterol can lead to
spatiotemporal re-partitioning of protein receptors in CD4 T-cells.
To this, a large body of evidence indicates that pharmacological
alterations in rafts composition like changes in cholesterol content
are sufficient to induce re-distribution of protein receptors and
their signaling modules in the plasma membrane [reviewed in
[77]. A question that remains to be addressed is to what extent
squalene enrichment of membrane cholesterol versus squalene
itself leads to re-distribution of protein receptors in T-cells? That is
because squalene administration in mice up-regulated expression
of HMG Co reductase, a critical up-stream enzyme required not
only for cholesterol synthesis, but also for generation of small
geranylgeranyl and farnesyl radicals actively involved in protein
trafficking from cytosol to the plasma membrane [reviewed in
[78]. This seems worthy of further investigation, as early studies
showed that squalene itself protects rats against cyclophospha-
mide-induced toxicity by scavenging free radicals and reactive
oxidative species [79].
Besides increasing the number of resting CD4 T-cells, squalene
enrichment of membrane cholesterol sensitized the Th1 signaling
modules in the absence of T-cell stimulation, i.e., STAT-4, STAT-
5, and TCR/ZAP-70. Th1 sensitization was significantly aug-
mented in the presence of increased IL-12 secretion by APCs. IL-
12 secreted by macrophages and dendritic cells is a well known
inflammatory Th1 inducing cytokine whose synthesis is contrib-
uted by TLR3 and TLR4 using MyD88 as a common adaptor
molecule for down-stream signaling [80]. Although the effect of
cholesterol loading in APCs was not the focus of this study, the
intimate mechanism by which cholesterol-rich rafts interferes with
TLRs signaling and genetic regulation of IL-12 synthesis in APCs
is worth being explored. In this study, squalene enrichment of
membrane cholesterol in resting CD4 T-cells led to a spatiotem-
poral re-distribution of IL-2Rb2 subunit in the rafts according to
CLSM analysis, a driving event towards Th1 differentiation.
Furthermore, squalene enrichment of membrane cholesterol in the
presence of antigen or CD3/CD28 stimulation led to a vigorous
Figure 6. Squalene induced accumulation of membrane cholesterol in resting CD4 T cells favors Th1 polarization under antigen-
specific or non antigen specific stimulation. (A) Isolated adherent splenocytes (APCs, 5610
5) from individual F1 mice treated or not with 180 mg
of squalene, were pulsed (+) or not pulsed (-) with HA110–120 synthetic peptide (40 mg/mL/10
6 cells) in vitro 7 days after squalene injection, and co-
cultured with negatively-sorted CD4 splenic T-cells (10
6 cells) from the same groups of mice, treated or not with squalene (Sq) (n=4/group). Various
cell co-culture combinations are shown on the X-axis, where (+) indicates presence and (–) indicates absence from the culture. Cell-culture
supernatants were collected 24–48 h later, and secretion of IL-2, IL-4, and IFN-c (Y-axis) was measured in pg/ml by Luminex. Bars represent average 6
SD. Differences among groups were highly significant (p,0.001) for cytokines with the following exceptions denoted as 1: For IL-4, co-culutre in lane
6 differed significantly from lane 5 (p=0.047) but not from lane 3 (p=0.097). No significant difference was observed between co-culture in lane 3 and
5 for any of the three cytokines. (B) Intracellular cytokine staining for IFN-c (left panels) and IL-4 (right panels) in splenic cells and CD4-gated splenic
cells from individual untreated (top panels) and squalene treated F1 mice (bottom panels) (n=3/group) were stimulated for 48 h with anti-CD3/CD28
Abs (2.5 mg each/10
6 cells). Shown are the overlapped FACS histograms of gated CD4
+ T cells synthesizing IL-4 or IFN-c (red cell events), and total
splenic cells (dark cell events) from squalene treated or untreated F1 mice, 7 days after squalene treatment. R1 gate indicates the low-proliferating cell
population whereas the R2 gate indicates the high proliferating cell population in each experiment. Dead cells are shown in the un-gated cell
population below the R1 gate. Shown is one of two representative experiments.
doi:10.1371/journal.pone.0038733.g006
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reactivity of antigen-specific, diabetogenic Th1 cells in a mouse
model for inducible T1D, and with previous findings showing that
cholesterol lowering statin therapy can lead to the beneficial
reversal of Th1 to Th2 polarization in psoriasis patients associated
with hyperlipidemia [81].
Foxp3
+ T-reg cells represent a particular subset of the CD4 T-
cell population. A recent study showed that the number of splenic
T-regs peaked at 4 weeks and decreased gradually between 8 and
20 weeks during a cholesterol-rich diet in mice, and this coincided
with an increased number of inflammatory Th1 cells over the
same period of time [65]. The same study concluded that
hypercholesterolemia impairs the T-reg pool but not the migration
of inflammatory cells to atherosclerotic lesions. However, our data
showed that squalene enrichment of membrane cholesterol did not
alter the splenic T-reg frequency. We also found that unlike
conventional CD4 T-cells that were polarized toward a Th1
phenotype, the T-reg suppressogenic function remained unaltered
after squalene enrichment of membrane cholesterol in CD4 Foxp3
T-reg cells or CD4 T effector cells.
Together, these data revealed differential regulatory effects of
membrane cholesterol on the function of CD4 T-cell subsets,
suggesting that membrane cholesterol could be a new therapeutic
Figure 7. Squalene enrichment of membrane cholesterol
fosters the autoreactivity of antigen-specific Th1 diabetogenic
cells. (A) Diabetogenicity of antigen (HA110–120)-specific CD4 splenic
Th1 cells was determined in RAG2 KO, RIP-HA mouse model for
inducible type 1 diabetes (T1D). The HA110–120-specific CD4 splenic T-
cells (2610
5 cells) from either F1 mice (Foxp3-GFP
+/2 TCR-HA
+/2 mice)
(filled circle), or from parental Foxp3-GFP
+/
+ mice (open circle) were
infused alone, or in combination with Foxp3-GFP sorted splenic cells
(2610
5 cells) from Fl mice (filled triangle) or Foxp3-GFP sorted cells
(2610
5 cells) from parental Foxp3-GFP
+/
+ mice (open triangle) into
RAG2 KO, RIP-HA Tg recipient mice (n=5 mice/group). Shown is the
mean glycemia values for individual mice in each group 6 SD.
Horizontal dark line indicates the upper limit of euglycemia (200 mg/
dL) previously determined in a large cohort of non manipulated RAG2
KO RIP-HA Tg recipients (n=20). Of note, only the antigen (HA110–120)-
specific CD4 splenic T-cells, but not T-regs or other non-antigen (HA110–
120)-specific T-cells were able to induce hyperglycemia in RAG2 KO, RIP-
HA Tg recipients. (B) Diabetogenicity of antigen (HA110–120)-specific
CD4 splenic Th1 cells from squalene treated F1 mice was tested in the
same RAG2 KO, RIP-HA mouse model for inducible T1D described in
panel A. The HA110–120-specific CD4 splenic T-cells (2610
4 cells) from
squalene treated (180 mg/mouse) or untreated F1 mice were first
depleted of Foxp3
+ splenic cells 7 days post-squalene treatment, and
then infused i.p. in RAG2 KO, RIP-HA Tg recipients. Shown is the
cumulative incidence of hyperglycemia (X-axis) from two separate
experiments, n=5 mice/group/experiment. Cumulative incidence of
hyperglycemia was calculated by dividing the number of mice per
group that developed two consecutive readings of hyperglycemia
(.200 mg/dL) at various intervals of time by the total number of mice
and then multiplied by 100.
doi:10.1371/journal.pone.0038733.g007
Figure 8. Squalene enrichment of membrane cholesterol in
CD4
+Foxp3
+ T-reg cells does not alter their suppressogenic
function. (A) T-reg suppression of HA110–120 -specific CD4 T-effector (T-
eff) cells from untreated or squalene treated (single dose of 180 mg/
mouse) F1 mice (n=4/group) has been tested in an in vitro suppression
assay. Isolated HA110–120-pulsed APCs (5610
5) were co-cultured for 48 h
with FACS-sorted HA-specific CD4
+ T-eff cells (10
6 cells) and FACS-
sorted Foxp3-GFP
+ T-regs (10
6 cells) from either untreated or squalene
treated (Sq) F1 mice. Various cell co-culture combinations from
individual mice are shown in the X-axis, where (+) indicates the
presence and (–) indicates the absence of cells in the culture system.
Cell-culture supernatants from each Treg/T-eff combination were then
measured for secreted IFN-c (Th1 cytokine) and IL-4 (Th2 cytokine) by
Luminex (Y-axis). No significant changes were observed when
compared different co-cultures as specified (brackets, *p values.0.05).
(B) Quantitative real-time RT-PCR measured the T-bet mRNA extracted
from triplicate wells of each T-reg/T-eff cells combination described in
panel A. The Y axis indicates the mean fold increase in mRNA expression
level relative to endogenous 18S rRNA control 6 SD. The mRNA relative
values were normalized to the untreated T-eff co-cultures with HA-
pulsed APCs (reference control sample). Shown is one of two
representative experiments. No significant changes were observed
when compared different co-cultures as specified (brackets, *p va-
lues.0.05).
doi:10.1371/journal.pone.0038733.g008
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Supporting Information
Figure S1 Squalene administration leads to accumula-
tion of membrane cholesterol in several lymphocyte
subsets. F1 hybrid mice (n=5/group) were injected i.p. (dark
plots) or not (light plots) with a single dose of squalene (180 mg/
mouse) and 7 days later splenocytes were individually stained for
CD8, CD22.2, CD19, or CD11c, and co-stained with CD3 and
Filipin III. Shown are the percent values 6 SD and MFI values of
Filipin III 6 SD collected among 100–800 cell events in gated
populations from one of two representative experiments. Values to
the left correspond to untreated mice, and values to the right
correspond to squalene treated mice.
(TIF)
Figure S2 Effect of recurrent administration of squa-
lene on the cholesterol metabolism. (A) Serum lipid
electrophoresis of F1 mice treated i.p. with 4 doses of squalene
(red line) given once a week (180 mg/dose/mouse) (lanes 1–2), or
untreated mice (lanes 3–4) as analyzed 7 days after the last
squalene injection. Shown are the LDL, VLDL, and HDL serum
fractions of cholesterol from 4 of 10 mice analyzed. The
electrophoretic bands were scanned by densitometry and quanti-
fied using the SCION analysis software (right panel). Of note, a
recurrent squalene treatment resulted in increased HDL serum
fraction. (B) Liver accumulation of cholesterol in individual
untreated or squalene treated (180 mg/mouse) F1 mice analyzed 7
days after the last squalene injection by staining frozen liver
sections with Sudan IV and hematoxylin (n=5 mice/group). Upper
panel shows the presence of cholesterol (reddish spots) in a sample
of fat tissue (control cholesterol staining). Lower left panel, untreated
F1 mouse at X40 magnification. Lower right panel, F1 mouse
treated with 4 doses of squalene at X40 magnification. Of note,
slight increase in cholesterol accumulation (reddish areas) was
detected in mice treated with 4 doses. Shown is one representative
liver section from each group of mice.
(TIF)
Figure S3 Squalene enrichment of membrane choles-
terol in unstimulated APCs alters their cytokine secre-
tion. Unstimulated APCs from F1 mice untreated (dark bars) or
squalene treated mice (180 mg/mouse) (light bars) were measured
for IL-12, IL-6, and IL-1a secretion in vitro, 7 days after squalene
treatment (n=5 mice/group). Cell culture supernatants from 2-
day cultures of adherent lymphocytes harvested from individual
spleens of each group of mice were measured by Luminex. Of
note, only IL-12 secretion by unstimulated APCs from squalene
treated mice was significantly increased (*p,0.01).
(TIF)
Figure S4 Alteration in T-bet and GATA-3 mRNA
expression levels in splenic cells enriched for membrane
cholesterol and stimulated with CD3/CD28 Abs. Quan-
titative real-time RT-PCR of T-bet and GATA-3 mRNA
extracted from in vitro CD3/CD28-stimulated splenocytes from
individual F1 mice treated i.p. or not with 1 dose of squalene
(180 mg) (n=5 mice/group) was carried out 7 days after squalene
injection. Y axis indicates the mean fold increase in mRNA
expression level relative to the endogenous 18S rRNA expression
level (control 6 SD). Shown are two combined separate
experiments (*p value,0.01).
(TIF)
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